Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00350844 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension

StatusTerminated
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗
Why the trial stopped
Low subject accrual

Amendment history

See every version on ClinicalTrials.gov ↗

  1. Stopped

    Status: Recruiting to Terminated

    v5

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to test the hypothesis that hydroxyurea is effective for the specific treatment of secondary pulmonary hypertension found on screening in children and young adults with sickle cell disease.
Trial Details
NCT Number NCT00350844
Lead Sponsor Ann & Robert H Lurie Children's Hospital of Chicago
Conditions Sickle Cell Disease, Pulmonary Hypertension
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov